During the past decade, Hôpital Guillaume et René Laënnec; Service Neurologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Guillaume et René Laënnec; Service Neurologie" #1 collaborator was "Biogen" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Guillaume et René Laënnec; Service Neurologie" are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Acute Stroke" (1 trials), "Migraine" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Hôpital Guillaume et René Laënnec; Service Neurologie" in a lesser frequency.

Most popular intervention types in "Hôpital Guillaume et René Laënnec; Service Neurologie" are "Drug" (5 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Placebo" (2 trials), "Questionnaire" (2 trials), "Constraint-induced movement therapy" (1 trials) and "Ocrelizumab 300 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Guillaume et René Laënnec; Service Neurologie" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Guillaume et René Laënnec; Service Neurologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hôpital Guillaume et René Laënnec; Service Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Guillaume et René Laënnec; Service Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".